Join Saira Chowdhury (Principal Oncology Dietitian at Guy’s and St Thomas’ NHS Foundation Trust) for this webinar as she explores the role of pancreatic enzyme therapy (PET) in the management of cancer patients, particularly those with pancreatic insufficiency due to cancer treatments or the cancer itself. Experts will discuss the clinical benefits of enzyme replacement, its impact on digestive function, and how it can improve quality of life in oncology patients. The session will cover current evidence, practical guidelines, and real-world case studies to provide a comprehensive understanding of this therapeutic approach.
Saira is experienced and highly specialised oncology dietitian dietitian with a special interest in GI cancers and GI late effects of treatment. I have 20 years of clinical experience working within the NHS at a large teaching hospital in London with a demonstrated history of working within a specialist multidisciplinary team to provide support to patients across the treatment care pathway. Skilled in delivering a range of Cancer services including but not limited to, assessment and Nutrition, Oncology, Dietetics, Clinical Research & management, advanced communication skills, University Lecturing, Supervisory Skills and Scientific Writing.
Learning Outcomes:
- Understand the role of pancreatic enzymes in managing cancer-related malabsorption and digestive issues.
- Review the indications and benefits of pancreatic enzyme therapy in cancer patients.
- Identify potential complications and how to manage them when using pancreatic enzyme therapy.
- Examine the latest research and clinical evidence supporting the use of pancreatic enzymes in oncology.
- Learn practical guidelines and dosing strategies for incorporating pancreatic enzyme therapy in cancer care.
